Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01331668

BIOBANK Renal Transplantation University Hospitals Leuven

This study aims to maintain a prospective biobank of human samples obtained from donors and recipients of renal allografts, including biopsy tissue, peripheral blood samples and urine samples.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Nephrology and Renal Transplantation - University Hospitals Leuven

Leuven, BE, 3000, Belgium

Location status: Recruiting

Location contact

Maarten Naesens, MD, PhD

CONTACT

[email protected]

32 16344580

Maarten Naesens, MD, PhD

PRINCIPAL_INVESTIGATOR

About this study

Clinical data and bio-specimens are prospectively collected and stored for undefined future translational research projects.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • renal transplant recipients/donors

Exclusion criteria

  • none

Treatment and study plan

Primary outcomes

  1. Renal allograft survival

    Time frame: 50 years after transplantation

Study contacts

Contact information is provided by the study sponsor or research team.

Maarten Naesens, MD, PhD

CONTACT

[email protected]

32 16344580

Sponsors and collaborators

Lead sponsor

Universitaire Ziekenhuizen KU Leuven

Other

Registry information

Important dates

Study start
2004
Primary completion
2099
Study completion
2099
First posted
Apr 8, 2011
Registry last updated
May 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.